Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  Pacific Biosciences of California    P09

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Deutsche Boerse Ag
01/17/2017 01/18/2017 01/19/2017 01/20/2017 01/23/2017 Date
4.421(c) 4.378(c) 4.244(c) 4.196(c) 4.276(c) Last
1 200 0 257 0 0 Volume
-1.47% -0.97% -3.06% -1.13% +1.91% Change
More quotes
Financials ($)
Sales 2016 87,7 M
EBIT 2016 -73,3 M
Net income 2016 -75,9 M
Debt 2016 15,0 M
Yield 2016 -
Sales 2017 110 M
EBIT 2017 -71,8 M
Net income 2017 -75,2 M
Debt 2017 1,00 M
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
EV / Sales2016 4,99x
EV / Sales2017 3,85x
Capitalization 422 M
More Financials
Company
Pacific Biosciences of California, Inc. develops, manufactures and markets sequencing systems to help scientists resolve genetically complex problems.The company has developed a technology to study the synthesis and regulation of DNA combining recent advances in nanofabrication, biochemistry,... 
More about the company
Surperformance© ratings of Pacific Biosciences of Cal
Trading Rating : Investor Rating :
More Ratings
Latest news on PACIFIC BIOSCIENCES OF CAL
01/17 PACIFIC BIOSCIENCES OF CALIFORNIA : Novogene Agrees to Buy Ten PacBio Sequel Sys..
01/16 Novogene Agrees to Buy Ten PacBio Sequel Systems for DNA Sequencing Services
01/14 PACIFIC BIOSCIENCES OF CALIFORNIA : More Than 115 Presentations and Posters Feat..
01/13 NASDAQ : PACB Shareholder Notice: Investigation over Possible Securities Laws Vi..
01/12 More Than 115 Presentations and Posters Feature PacBio SMRT Sequencing to Dec..
01/10 PACIFIC BIOSCIENCES OF CALIFORNIA : UPDATE -- Pacific Biosciences Improves Key A..
01/10 PACIFIC BIOSCIENCES OF CALIFORNIA : Improves Key Applications on the Sequel Syst..
01/09 PACIFIC BIOSCIENCES OF CALIFORNIA : UPDATE — Pacific Biosciences Improves ..
01/09 UPDATE -- Pacific Biosciences Improves Key Applications on the Sequel System ..
01/09 Pacific Biosciences Improves Key Applications on the Sequel System with New C..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
01/23 PHILIPS LIGHTING : sees brighter 2017 as fourth-quarter profit disappoints
01/19 Davos CEOs 'go local' on supply chain in Trump era
01/08DJCorrection to Parkinson's Therapy Story
01/08DJParkinson's Therapy Gets Fresh Look From Device Makers
01/08DJParkinson's Therapy Gets Fresh Look From Device Makers
More sector news : Advanced Medical Equipment & Technology - NEC
Advertisement
Chart PACIFIC BIOSCIENCES OF CAL
Duration : Period :
Pacific Biosciences of Cal Technical Analysis Chart | P09 | US69404D1081 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 7,46 $
Spread / Average Target 64%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Mike W. Hunkapiller Executive Chairman, President & CEO
Susan K. Barnes Executive VP, Chief Financial & Accounting Officer
Stephen W. Turner Chief Technology Officer & Vice President
James Michael Phillips Senior Vice President-Research & Development
Jonas Korlach Chief Scientific Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
PACIFIC BIOSCIENCES OF..14.77%422
THERMO FISHER SCIENTIF..1.20%56 690
DANAHER CORPORATION2.77%55 703
BOSTON SCIENTIFIC CORP..9.48%32 544
PHILIPS-3.72%27 770
INTUITIVE SURGICAL, IN..3.29%25 447
More Results